Meditrial
Paola Antonini's work experience includes their current role as Chief Scientific Officer at Meditrial since April 2022. Prior to this, they held the position of VP of Clinical Science at Telix Pharmaceuticals Limited starting from October 2021. Paola also worked as CMSO at Great Health Science from April 2021. Before that, they served as the Head of Clinical Research at Great Health Science from January 2021. Additionally, Paola Antonini was the Director of Research Project in Longevity - Epidemiological study at CIAO study from January 2016. Paola was the Global Head of Clinical Science at Almirall from July 2020 to December 2020. Paola also worked as the Medical Director at Nouscom AG from January 2019 to June 2020. Other positions held by Antonini include being the Scientific Coordinator at GREAT Network Italy from February 2018 to December 2018. Paola held various roles at Worldwide Clinical Trials, including Sr VP Scientific Affairs from February 2013 to August 2016. Paola also served in several positions at Merck Sharp & Dohme Italy, starting as the Medical Affairs Director in July 1983 and ending as the Clinical Research Manager in December 1996.
Paola Antonini's education history begins in 1978 when they enrolled at Sapienza Università di Roma to pursue a degree in Medicine. Paola completed their MD program in 1983. Following this, from 1983 to 1987, Paola Antonini attended Università degli Studi di Firenze, specializing in Pharmacology as part of their medical studies. It is unclear when their time at Università degli Studi di Firenze ended and if they obtained any further degrees or field of study.
This person is not in any offices
Meditrial
Meditrial is a leading provider of clinical trial services and digital cloud-based solutions for the lifesciences industry. As a Clinical Research Organization (CRO), Meditrial is renowned as the go-to partner by companies developing breakthrough innovations that require a clearly defined path to first-in-man and pivotal clinical studies. Established in 2008, today Meditrial is a trusted resource for large corporations as well as start-ups requiring support and resources to execute trials in the Uniteef States and Europe. Headquartered in Zürich, Meditrial has offices in Berlin, Rome, London and New York. Learm more: www.meditrial.net - www.catchtrial.com - www.mastertrial.com Despite the everchanging regulation and increasing difficulty to obtain approval for clinical investigations, Meditrial has a remarkable record of 100% success in assisting clients to execute studies in medical centers of excellence throughout Europe and United States. Meditrial's software solutions allow customers to successfully manage large global trials and registries while monitoring the results in large number of patients. Meditrial’s core strength lies in its clinical experts’ proficiency, alongside with its integrated digital platform for elearning, data capture and analytics. The organization provides a set of systems and tools to minimize complexity of clinical trials and regulatory approvals Meditrial is extremely proud to be one of the first—and very few—CROs certified by ISO 9001, ISO 13485 and ISO 27001 for information security.